MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/jcp.0000000000000633

Медицинская библиотека · Journal of clinical psychopharmacology · 2017

The COMT Val158Met Polymorphism Is Associated With Response to Add-on Dextromethorphan Treatment in Bipolar Disorder.

Lee Sheng-Yu, Chen Shiou-Lan, Wang Tzu-Yun, Chang Yun-Hsuan, Chen Po See, Huang San-Yuan, Tzeng Nian-Sheng, Wang Liang-Jen, Lee I Hui, Chen Kao Ching, Yang Yen Kuang, Lu Ru-Band

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

PURPOSE/

BACKGROUND

We previously conducted a randomized, double-blind, controlled, 12-week study evaluating the effect of add-on dextromethorphan (DM), a noncompetitive N-methyl-D-aspartate receptor antagonist, on patients with bipolar disorder (BD) treated using valproate (VPA), which showed negative clinical differences. The genetic variation between each individual may be responsible for interindividual differences. The catechol-O-methyltransferase (COMT) gene has been a candidate gene for BD. In the current study, we investigated whether the COMT Val158Met polymorphism predicts treatment response to VPA + add-on DM and to VPA + placebo.

METHODS/PROCEDURES: Patients with BD (n = 309) undergoing regular VPA treatments were randomly assigned to groups given either add-on DM (30 mg/d) (n = 102), DM (60 mg/d) (n = 101), or placebo (n = 106) for 12 weeks. The Hamilton Depression Rating Scale and Young Mania Rating Scale were used to evaluate clinical response during weeks 0, 1, 2, 4, 8, and 12. The genotypes of the COMT Val158Met polymorphism were determined using polymerase chain reaction plus restriction fragment length polymorphism analysis. To adjust for within-subject dependence over repeated assessments, multiple linear regression with generalized estimating equation methods was used.

FINDINGS/

RESULTS

When stratified by the COMT Val158Met genotypes, significantly greater decreases in Hamilton Depression Rating Scale scores were found in the VPA + DM (30 mg/d) group in patients with the Val/Met genotype (P = 0.008).

CONCLUSIONS

We conclude that the COMT Val158Met polymorphism may influence responses to DM (30 mg/d) by decreasing depressive symptoms in BD patients.

Для цитирования: Lee Sheng-Yu, Chen Shiou-Lan, Wang Tzu-Yun, Chang Yun-Hsuan, Chen Po See, Huang San-Yuan, Tzeng Nian-Sheng, Wang Liang-Jen, Lee I Hui, Chen Kao Ching, Yang Yen Kuang, Lu Ru-Band. The COMT Val158Met Polymorphism Is Associated With Response to Add-on Dextromethorphan Treatment in Bipolar Disorder.. Journal of clinical psychopharmacology. 2017. DOI: 10.1097/jcp.0000000000000633.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.